Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.64 |
| ▸ | MEN1 | O00255 | 9/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.64 |
| ▸ | TP53 | P04637 | 6/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.64 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.64 |
| ▸ | AR | P10275 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17786435 | 0.84 | KMT2A (0.50) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL471860 | 0.84 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL31675811 | 0.83 | NMUR2 (0.71) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL290080 | 0.83 | NMUR2 (0.71) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL1421375 | 0.83 | NMUR2 (0.62) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL16586869 | 0.81 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL15676117 | 0.81 | NMUR2 (0.68) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL6095363 | 0.80 | NTRK1 (0.63) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL3062193 | 0.80 | KDM4E (0.72) | NMUR2KDM4EMEN1KMT2ACYP3A4 | |
| SCHEMBL2746872 | 0.80 | MEN1 (0.90) | NMUR2KDM4EMEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7211414-B2 | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | VISIGEN BIOTECHNOLOGIES, INC. (US) | 2007-05-01 | — | — | US | claimed |
| EP-3415641-B1 | METHOD FOR ANALYSIS OF MOLECULES | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-3415641-A1 | METHOD FOR ANALYSIS OF MOLECULES | Pacific Biosciences Of California, Inc. (US) | 2018-12-19 | — | — | EP | disclosed |
| US-20180100191-A1 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR INHIBITING PYROPHOSPHOROLYSIS | VISIGEN BIOTECHNOLOGIES, INC. | 2018-04-12 | — | — | US | disclosed |
| US-9845500-B2 | Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis | Life Technologies Corporation (US) | 2017-12-19 | — | — | US | disclosed |
| US-20170343479-A1 | APPARATUS AND METHOD FOR PERFORMING NUCLEIC ACID ANALYSIS | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2017-11-30 | — | — | US | disclosed |
| US-9709503-B2 | Apparatus and method for performing nucleic acid analysis | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-9588051-B2 | Apparatus and method for performing nucleic acid analysis | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2017-03-07 | — | — | US | disclosed |
| US-20170002409-A1 | APPARATUS AND METHOD FOR PERFORMING NUCLEIC ACID ANALYSIS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2017-01-05 | — | — | US | disclosed |
| US-20160244822-A1 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR INHIBITING PYROPHOSPHOROLYSIS | Life Technologies Corporation | 2016-08-25 | — | — | US | disclosed |
| US-20060061755-A1 | Apparatus and method for analysis of molecules | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2006-03-23 | — | — | US | disclosed |
| US-20060061754-A1 | Arrays of optical confinements and uses thereof | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2006-03-23 | — | — | US | disclosed |
| US-20060063264-A1 | Apparatus and method for performing nucleic acid analysis | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2006-03-23 | — | — | US | disclosed |
| US-20060062531-A1 | Fabrication of optical confinements | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2006-03-23 | — | — | US | disclosed |
| EP-1354064-A2 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR ALTERING MONOMER INCORPORATION FIDELITY | Visigen Biotechnologies, Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| US-20030134807-A1 | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | Life Technologies Corporation | 2003-07-17 | — | — | US | disclosed |
| WO-2002044425-A2 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR ALTERING MONOMER INCORPORATION FIDELITY | VISIGEN BIOTECHNOLOGIES, INC. (US) | 2002-06-06 | — | — | WO | disclosed |
| US-6399335-B1 | MIXING POLYMERASE AND NUCLEOSIDE TRIPHOSPHATE HAVING A GAMMA PHOSPHATE PHOSPHOESTER-LINKED FUNCTIONAL GROUP, INCUBATING SO THAT POLYMERASE CATALYZES CLEAVAGE BETWEEN ALPHA AND BETA PHOSPHATES AND LIBERATES PYROPHOSPHATE WITH FUNCTIONAL GROUP | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2002-06-04 | — | — | US | disclosed |
| US-5552551-A | COLORS FOR PHOSPHORESCENCE | FLORIDA STATE UNIVERSITY (US) | 1996-09-03 | — | — | US | disclosed |
| WO-1995003343-A1 | PROTON-TRANSFER, LOW SELF-ABSORBING CHROMOPHORES FOR USE IN SCINTILLATORS | FLORIDA STATE UNIVERSITY (US) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180100191-A1 | ENZYMATIC NUCLEIC ACID SYNTHESIS: COMPOSITIONS AND METHODS FOR INHIBITING PYROPHOSPHOROLYSIS | RNGTT, PPA1, PNP | NMUR2 3860/4885KDM4E 2933/4885MEN1 3457/4885 |
| US-20030134807-A1 | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity | RNGTT, PNP, MTAP | NMUR2 3477/4885KDM4E 2908/4885MEN1 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.